Best Negative Data Prize
Call for applications
The Best Negative Data Prize is a collaboration between ECNP and U.S.-based non-profit research organisation Cohen Veterans Bioscience, under the aegis of the Global Preclinical Data Forum (GPDF), to recognise published “negative” scientific results or results of studies that do not confirm the expected outcome or original hypothesis.
The award is conferred at the ECNP Congress and comes with a EUR 10,000 prize provided by Cohen Veterans Bioscience.
How to apply
Corresponding authors may submit their papers directly on the Global Preclinical Data Forum (GPDF) website via the submission link.
The deadline to apply is 31 May 2022.
The review committee will select and inform the winner by 1 September 2022.
The public announcement and presentation of the prize will take place at the 35th ECNP Congress, 15-18 October 2022 in Austria, Vienna where the winner will be expected to present a talk about his or her negative data results paper.
For the full press announcement of the award, read here.
The European College of Neuropsychopharmacology (ECNP) is the parent organisation hosting the Preclinical Data Forum Network. The ECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. Read more.
About Cohen Veterans Bioscience
Cohen Veterans Bioscience is a national, nonpartisan 501(c)(3) research organisation dedicated to fast-tracking the development of diagnostic tests and personalised therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders. To support & learn more about our research efforts, visit this page.
About the Global Preclinical Data Forum (GPDF)
The GPDF, comprised of members from the academic, non-profit, government, publishing and industry sectors, is a joint US and European initiative to encourage global collaboration to address the challenge of ensuring that preclinical research is reproducible, robust and translatable to support disease research utility for clinical research and development. More info.
Please contact Anton Bespalov (PAASP) via e-mail.
View here previous Best Negative Data Prize winners.